Novo Nordisk, the Denmark based pharma giant, has finally launched its hugely popular diabetes and weight-loss medicine, Ozempic, in the Indian market. Ozempic has recently garnered global recognition ...

The Genetic InFormatics Trial (GIFT) of Warfarin Therapy to Prevent DVT—the first trial to quantify the benefit of pharmacogenetic dosing of warfarin on clinical events—found that genotype-guided ...

WASHINGTON (March 19, 2017) - Using genetic testing to help personalize doses of warfarin therapy given to patients undergoing elective orthopedic surgery appears to lower the risk of combined adverse ...